These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2091240)
21. [The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium]. De Caterina R; Lenzi S G Ital Cardiol; 1998 Feb; 28(2):158-67. PubMed ID: 9534057 [TBL] [Abstract][Full Text] [Related]
22. [Lipoprotein (a)--a mysterious factor in atherogenesis]. Jelaković B; Laganović M; Kuzmanić D Lijec Vjesn; 2002; 124(11-12):366-71. PubMed ID: 12679978 [TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
24. Lipids and plasma fibrinogen: early and late composition of the atherosclerotic plaque. Smith EB Cardiologia; 1994 Dec; 39(12 Suppl 1):169-72. PubMed ID: 7634262 [TBL] [Abstract][Full Text] [Related]
25. Hypertension, antihypertensive drugs, and atherogenesis. Mechanisms and clinical implications. Chobanian AV J Clin Hypertens; 1986 Sep; 2(3 Suppl):148S-157S. PubMed ID: 2878982 [TBL] [Abstract][Full Text] [Related]
27. [Pathogenetic importance of prostacyclin in atherosclerosis]. Efimov VV; Ladnyĭ AI Ter Arkh; 1985; 57(9):142-8. PubMed ID: 3909478 [No Abstract] [Full Text] [Related]
28. [Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms]. Lenzi S; Scanu A; De Caterina R G Ital Cardiol; 1996 Oct; 26(10):1203-25. PubMed ID: 9005165 [TBL] [Abstract][Full Text] [Related]
29. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Smith EB Clin Haematol; 1986 May; 15(2):355-70. PubMed ID: 3524931 [TBL] [Abstract][Full Text] [Related]
30. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Chapman MJ; Guérin M; Bruckert E Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339 [TBL] [Abstract][Full Text] [Related]
31. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. Bradley WA; Gianturco SH J Intern Med Suppl; 1994; 736():33-9. PubMed ID: 7986306 [TBL] [Abstract][Full Text] [Related]
33. The complementary interaction of epidemiological and experimental animal studies: a key foundation of the preventive effort. Wissler RW; Vesselinovitch D Prev Med; 1983 Jan; 12(1):84-99. PubMed ID: 6844321 [TBL] [Abstract][Full Text] [Related]
34. Atherogenesis: hemodynamics, vascular geometry, and the endothelium. Nerem RM Biorheology; 1984; 21(4):565-9. PubMed ID: 6487767 [TBL] [Abstract][Full Text] [Related]
35. A spatial approach to transcriptional profiling: mechanotransduction and the focal origin of atherosclerosis. Davies PF; Polacek DC; Handen JS; Helmke BP; DePaola N Trends Biotechnol; 1999 Sep; 17(9):347-51. PubMed ID: 10461179 [TBL] [Abstract][Full Text] [Related]
36. Implications of the monoclonal character of human atherosclerotic plaques. Benditt EP Beitr Pathol; 1976 Sep; 158(4):405-16. PubMed ID: 985299 [TBL] [Abstract][Full Text] [Related]
37. The elusive local factor in atherosclerosis. Stehbens WE Med Hypotheses; 1997 Jun; 48(6):503-9. PubMed ID: 9247894 [TBL] [Abstract][Full Text] [Related]
38. Atherosclerosis: cell biology and lipoproteins. Jones DB Curr Opin Lipidol; 1994 Jun; 5(3):U80-4. PubMed ID: 7952906 [No Abstract] [Full Text] [Related]
40. Neoplasia of the arterial wall: role in atherosclerosis. Corbett SC; Cartwright RA Med Hypotheses; 1980 Apr; 6(4):389-400. PubMed ID: 7402137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]